Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Mark Soloway Stories

2013-06-26 12:59:24

Use of advanced treatment technologies for prostate cancer, such as intensity-modulated radiotherapy and robotic prostatectomy, has increased among men with low-risk disease, high risk of noncancer mortality, or both, a population of patients who are unlikely to benefit from these treatments, according to a study in the June 26 issue of JAMA. "Prostate cancer is a common and expensive disease in the United States. In part because of the untoward morbidity of traditional radiation and...

2013-05-30 10:46:24

Researchers have identified a sub-group of cells that could contribute to prostate cancer recurrence, opening up new ways to treat the disease, which claims more than 3000 lives a year in Australia. Published today in Science Translational Medicine, a study led by Monash University researchers has found prostate cancer cells that survive androgen withdrawal treatment. Previously unidentified, these cells are potential targets for future treatments. As they are present early in disease...

2013-02-14 08:27:54

TALLAHASSEE, Fla., Feb. 14, 2013 /PRNewswire/ -- Today, the findings of the largest reported study on prostate biopsies were released at the American Society of Clinical Oncology Genitourinary Cancers Symposium in Orlando. The research confirmed that cancer detection rates are enhanced when 10 to 12-specimens are obtained during the biopsy. "The study, which included over 4.2 million specimens collected from nearly 440,000 biopsies, confirms that biopsy regimens with 10 to 12 specimen...

2012-11-02 14:52:12

With active surveillance many men with prostate cancer could dispense with radiation treatment and surgery, and thus avoid adverse effects such as incontinence and impotence. This is the outcome of a study of almost 1,000 men diagnosed with prostate cancer conducted at Sahlgrenska Academy, University of Gothenburg, Sweden. The introduction of PSA tests, which are used to screen for prostate cancer, offers early tumor detection, reducing mortality rates. At the same time, prostate cancer is...

2012-10-30 19:12:39

Two MD Anderson-led studies conclude that patients' urinary, bowel function safe-guarded Two studies led by The University of Texas MD Anderson Cancer Center have found that proton therapy preserves the quality of life, specifically urinary and bowel function, in men treated with this targeted radiation modality for prostate cancer. Both studies, led by Andrew K. Lee, M.D., M.P.H., associate professor in MD Anderson's Department of Radiation Oncology, will be presented in a poster...

2012-10-03 10:23:38

CAMPBELL, Calif., Oct. 3, 2012 /PRNewswire-iReach/ -- The Northern California Prostate Cancer Center (NCPCC), a partnership between AKSM/Oncology and Urological Surgeons of Northern California (USNC), is the first prostate-only radiation treatment center in California to earn the high honor of a three-year term of accreditation in radiation oncology. (Photo: http://photos.prnewswire.com/prnh/20121003/CG86106) NCPCC is the latest in a rapidly growing list throughout the United States of...